Experience

CASE STUDY:

Chronic Pain Program - Phase 2 - US - Rare Disease

A biotech company retained PatientCentra to rescue their phase II, US chronic pain program when the existing CRO was unable to recruit efficiently. The target patient had a very specific, rare pain condition called Complex Regional Pain Syndrome (or CRPS), which was generally associated with pain in the foot, leg and groin. PatientCentra was quickly able to get the program back on track and fully enrolled with the following results:

• Implemented multi-channel digital outreach with campaigns across social media, search engines, website networks and mobile platforms
• Aggressively targeted patients with pain in the foot, leg and groin as well as ‘neuropathy’ patients while carefully filtering out off-target patients with pain in the back, knee, head, arms, neck, etc.
• Reduced cost per pre-screened patient from $282 to $99 (a 65% reduction)
• Generated 850 online pre-screened patients resulting in 20 randomized patients, and most importantly got the study fully enrolled within 8 months.

To see the full case study and learn how PatientCentra can help resolve your clinical trial enrollment challenges, please contact us directly.

Dismiss

CASE STUDY:

Medical Device US Dermatology Study

A medical device company retained PatientCentra to execute digital patient recruitment for their US pivotal study seeking 400 patients.  PatientCentra quickly launched a multi-tactic campaign including multi-channel digital outreach (social, search, website networks, online communities, mobile), online pre-screening through a patient focused website and downstream patient tracking, with the following results:

• Referred more than 5700 qualified, pre-screened patients to participating sites
• Drove 300 randomized patients in 12 months
• Accounted for the majority (75%) of the total study enrollment goal
  

To see the full case study and learn how PatientCentra can help resolve your clinical trial enrollment challenges, please contact us directly

Dismiss

CASE STUDY:

Multiple Global Diabetes Trials

PatientCentra was asked to execute patient recruitment efforts across multiple phase III diabetes clinical trials in the US and globally.  To leverage efforts, PatientCentra employed a ‘platform approach’ by executing a comprehensive suite of services (locally-targeted digital outreach, country-compliant websites, automated online pre-screening & cross-screening across stuides, site collateral, local language translations, patient data management and rapid-response call centers) in six (6) countries across four (4) continents (US, Canada, Australia, Brazil, Mexico & China).   The results were rapid and effective:

• Pre-screened out 95% of patients prior to site visits, saving valuable time for sites and patients
• Reduced pre-screened patient cost by 34% by cross-screening across multiple trials
• Drove more than 730 screening appointments for high quality, motivated, pre-screened patients
• Drove more than 200 Randomizations (for a difficult sub-segment of diabetes) in less than 12 months

To see the full case study and learn how PatientCentra can help resolve your clinical trial enrollment challenges, please contact us directly

Dismiss

CASE STUDY:

A biotech company retained PatientCentra to rescue their phase II, US chronic pain program when the existing CRO was unable to recruit efficiently. The target patient had a very specific, rare pain condition called Complex Regional Pain Syndrome (or CRPS), which was generally associated with pain in the foot, leg and groin. PatientCentra was quickly able to get the program back on track and fully enrolled with the following results:

• Implemented multi-channel digital outreach with campaigns across social media, search engines, website networks and mobile platforms
• Aggressively targeted patients with pain in the foot, leg and groin as well as ‘neuropathy’ patients while carefully filtering out off-target patients with pain in the back, knee, head, arms, neck, etc.
• Reduced cost per pre-screened patient from $282 to $99 (a 65% reduction)
• Generated 850 online pre-screened patients resulting in 20 randomized patients, and most importantly got the study fully enrolled within 8 months.

To learn about how PateintCentra can help resolve your clinical trial enrolment challanges, please contact us directly.

Dismiss

CASE STUDY:

A biotech company retained PatientCentra to rescue their phase II, US chronic pain program when the existing CRO was unable to recruit efficiently. The target patient had a very specific, rare pain condition called Complex Regional Pain Syndrome (or CRPS), which was generally associated with pain in the foot, leg and groin. PatientCentra was quickly able to get the program back on track and fully enrolled with the following results:

• Implemented multi-channel digital outreach with campaigns across social media, search engines, website networks and mobile platforms
• Aggressively targeted patients with pain in the foot, leg and groin as well as ‘neuropathy’ patients while carefully filtering out off-target patients with pain in the back, knee, head, arms, neck, etc.
• Reduced cost per pre-screened patient from $282 to $99 (a 65% reduction)
• Generated 850 online pre-screened patients resulting in 20 randomized patients, and most importantly got the study fully enrolled within 8 months.

To learn about how PateintCentra can help resolve your clinical trial enrolment challanges, please contact us directly.

Dismiss

CASE STUDY:

A biotech company retained PatientCentra to rescue their phase II, US chronic pain program when the existing CRO was unable to recruit efficiently. The target patient had a very specific, rare pain condition called Complex Regional Pain Syndrome (or CRPS), which was generally associated with pain in the foot, leg and groin. PatientCentra was quickly able to get the program back on track and fully enrolled with the following results:

• Implemented multi-channel digital outreach with campaigns across social media, search engines, website networks and mobile platforms
• Aggressively targeted patients with pain in the foot, leg and groin as well as ‘neuropathy’ patients while carefully filtering out off-target patients with pain in the back, knee, head, arms, neck, etc.
• Reduced cost per pre-screened patient from $282 to $99 (a 65% reduction)
• Generated 850 online pre-screened patients resulting in 20 randomized patients, and most importantly got the study fully enrolled within 8 months.

To learn about how PateintCentra can help resolve your clinical trial enrolment challanges, please contact us directly.

Dismiss

CASE STUDY:

A biotech company retained PatientCentra to rescue their phase II, US chronic pain program when the existing CRO was unable to recruit efficiently. The target patient had a very specific, rare pain condition called Complex Regional Pain Syndrome (or CRPS), which was generally associated with pain in the foot, leg and groin. PatientCentra was quickly able to get the program back on track and fully enrolled with the following results:

• Implemented multi-channel digital outreach with campaigns across social media, search engines, website networks and mobile platforms
• Aggressively targeted patients with pain in the foot, leg and groin as well as ‘neuropathy’ patients while carefully filtering out off-target patients with pain in the back, knee, head, arms, neck, etc.
• Reduced cost per pre-screened patient from $282 to $99 (a 65% reduction)
• Generated 850 online pre-screened patients resulting in 20 randomized patients, and most importantly got the study fully enrolled within 8 months.

To learn about how PateintCentra can help resolve your clinical trial enrolment challanges, please contact us directly.

Dismiss

CASE STUDY:

A biotech company retained PatientCentra to rescue their phase II, US chronic pain program when the existing CRO was unable to recruit efficiently. The target patient had a very specific, rare pain condition called Complex Regional Pain Syndrome (or CRPS), which was generally associated with pain in the foot, leg and groin. PatientCentra was quickly able to get the program back on track and fully enrolled with the following results:

• Implemented multi-channel digital outreach with campaigns across social media, search engines, website networks and mobile platforms
• Aggressively targeted patients with pain in the foot, leg and groin as well as ‘neuropathy’ patients while carefully filtering out off-target patients with pain in the back, knee, head, arms, neck, etc.
• Reduced cost per pre-screened patient from $282 to $99 (a 65% reduction)
• Generated 850 online pre-screened patients resulting in 20 randomized patients, and most importantly got the study fully enrolled within 8 months.

To learn about how PateintCentra can help resolve your clinical trial enrolment challanges, please contact us directly.

Dismiss

CASE STUDY:

Chronic Pain Program - Phase 2 - US - Rare Disease

PatientCentra was retained to drive enrollment in a phase II US study targeting patients with a very specific, rare pain condition called Complex Regional Pain Syndrome (or CRPS), which was generally associated with pain in the foot, leg and groin.  CRPS is estimated to have a prevalence of ~82,000 in the US[1].  PatientCentra devised a mulit-channel digital outreach campaign with the following results:

• Implemented multi-channel digital outreach with campaigns across social media, search engines, website networks and mobile platforms
• Aggressively targeted patients with pain in the foot, leg and groin as well as ‘neuropathy’ patients while carefully filtering out off-target patients with pain in the back, knee, head, arms, neck, etc.
• Reduced cost per pre-screened patient from $282 to $99 (a 65% reduction)
• Generated 850 online pre-screened patients resulting in 20 randomized patients, and most importantly got the study fully enrolled within 8 months.

To see the full case study and learn how PatientCentra can help resolve your clinical trial enrollment challenges, please contact us directly

[1] Based on prevalence of 26.2 per 100,000 from Complex regional pain syndrome: a recent update, Goh, et al, Burns Trauma. 2017; 5:2

Dismiss

CASE STUDY:

US Medical Device Study

A medical device company retained PatientCentra to execute digital patient recruitment for their US pivotal study seeking 400 patients.  PatientCentra quickly launched a multi-tactic campaign including multi-channel digital outreach (social, search, website networks, online communities, mobile), online pre-screening through a patient focused website and downstream patient tracking, with the following results:

• Referred more than 5700 qualified, pre-screened patients to participating sites
• Drove 300 randomized patients in 12 months
• Accounted for the majority (75%) of the total study enrollment goal
  

To see the full case study and learn how PatientCentra can help resolve your clinical trial enrollment challenges, please contact us directly

Dismiss